Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06614569 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Follow-Up of Subjects Treated With AXO-AAV-GM2 for Tay-Sachs or Sandhoff Disease

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This study is to continue Long-Term Follow-Up of Patients who were previously treated with AXO-AAV-GM2 Gene Therapy as treatment for Tay-Sachs or Sandhoff Disease to follow the subjects through 5 years after their initial gene therapy treatment.
Trial Details
NCT Number NCT06614569
Lead Sponsor Terence Flotte
Conditions
(from sponsor)		 GM2 Gangliosidosis, Tay Sachs Disease, Sandhoff Disease
Related terms Gangliosidoses, GM2, Sandhoff Disease, Tay-Sachs Disease
Enrollment 7 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov